DK1047446T3 - Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf - Google Patents

Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf

Info

Publication number
DK1047446T3
DK1047446T3 DK99902294T DK99902294T DK1047446T3 DK 1047446 T3 DK1047446 T3 DK 1047446T3 DK 99902294 T DK99902294 T DK 99902294T DK 99902294 T DK99902294 T DK 99902294T DK 1047446 T3 DK1047446 T3 DK 1047446T3
Authority
DK
Denmark
Prior art keywords
methods
herpes simplex
vaccine composition
simplex virus
virus
Prior art date
Application number
DK99902294T
Other languages
English (en)
Inventor
Laure Aurelian
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of DK1047446T3 publication Critical patent/DK1047446T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99902294T 1998-01-16 1999-01-15 Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf DK1047446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/008,388 US6054131A (en) 1998-01-16 1998-01-16 Vaccine composition for herpes simplex virus and method of using
PCT/US1999/000920 WO1999036084A1 (en) 1998-01-16 1999-01-15 Vaccine composition for herpes simplex virus and methods of using

Publications (1)

Publication Number Publication Date
DK1047446T3 true DK1047446T3 (da) 2004-03-29

Family

ID=21731361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902294T DK1047446T3 (da) 1998-01-16 1999-01-15 Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf

Country Status (11)

Country Link
US (2) US6054131A (da)
EP (1) EP1047446B1 (da)
JP (1) JP2002509113A (da)
AT (1) ATE254474T1 (da)
AU (1) AU742281B2 (da)
CA (1) CA2318439A1 (da)
DE (1) DE69912925T2 (da)
DK (1) DK1047446T3 (da)
ES (1) ES2212521T3 (da)
PT (1) PT1047446E (da)
WO (1) WO1999036084A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
CA2612168A1 (en) * 2005-06-14 2006-12-21 Dnavec Corporation Methods for producing antibodies
CA2613310C (en) * 2005-06-23 2014-06-17 Baylor College Of Medicine Use of mutant herpes simplex virus-2 for cancer therapy
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
EP1948232A4 (en) * 2005-11-18 2010-09-22 Univ Ohio State Res Found VIRAL GENE PRODUCTS AND VACCINATION METHODS FOR PREVENTING ASSOCIATED VIRAL DISEASES
US7790203B2 (en) * 2005-12-13 2010-09-07 Lowder Tom R Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
JP5571380B2 (ja) * 2006-07-24 2014-08-13 ルミナス バイオサイエンシズ，インコーポレイテッド オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
ES2671710T3 (es) 2008-05-02 2018-06-08 Novadaq Technologies ULC Métodos para la producción y uso de eritrocitos cargados con sustancias para la observación y el tratamiento de la hemodinámica microvascular
CN102026668A (zh) 2008-05-14 2011-04-20 诺瓦达克技术公司 用于神经成像的包括与病毒组分结合的荧光染料的成像法和组合物
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
MY159500A (en) * 2009-05-22 2017-01-13 Genocea Biosciences Inc Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2012074881A2 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2013078299A1 (en) 2011-11-23 2013-05-30 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US10278585B2 (en) 2012-06-21 2019-05-07 Novadaq Technologies ULC Quantification and analysis of angiography and perfusion
WO2016049756A1 (en) 2014-09-29 2016-04-07 Novadaq Technologies Inc. Imaging a target fluorophore in a biological material in the presence of autofluorescence
EP3915467A1 (en) 2014-10-09 2021-12-01 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物
JP6931705B2 (ja) 2017-02-10 2021-09-08 ノバダック テクノロジーズ ユーエルシー オープンフィールドハンドヘルド蛍光イメージングシステムおよび方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4347127A (en) * 1981-01-29 1982-08-31 Gulf & Western Manufacturing Company Apparatus and method for froth flotation separation of the components of a slurry
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US5219567A (en) * 1982-03-24 1993-06-15 The University Of Birmingham Vaccine against herpes viruses
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine

Also Published As

Publication number Publication date
US6054131A (en) 2000-04-25
ATE254474T1 (de) 2003-12-15
US6207168B1 (en) 2001-03-27
JP2002509113A (ja) 2002-03-26
EP1047446A4 (en) 2001-12-19
DE69912925T2 (de) 2004-09-02
WO1999036084A1 (en) 1999-07-22
EP1047446A1 (en) 2000-11-02
AU2231299A (en) 1999-08-02
AU742281B2 (en) 2001-12-20
EP1047446B1 (en) 2003-11-19
ES2212521T3 (es) 2004-07-16
CA2318439A1 (en) 1999-07-22
PT1047446E (pt) 2004-04-30
DE69912925D1 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
DK1047446T3 (da) Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
DK1584685T3 (da) Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
ATE264863T1 (de) 28-epirapaloge
GB9711964D0 (en) Live attenuated vaccines
DZ2283A1 (fr) Composition de vaccin.
NO910728D0 (no) Fremgangsmaate for aa sementere olje- og gass-broenner.
DE69738271D1 (de) Rotavirus-impfstoff
NO20002504L (no) Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener
AU1508699A (en) Live attenuated influenza vaccine
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
ATE386049T1 (de) Epstein-barr virus type b ctl epitopen
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
DK1131414T3 (da) Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
BG101145A (en) USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPETIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
FI940150A (fi) Koostumuksia sementtiä varten ja sementit, jotka on saatu näistä koostumuksista
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
AU2231499A (en) Novel vaccine compositions for herpes simplex virus
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner
KR970703417A (ko) 유두종 바이러스 백신(Papillomavirus vaccines)
FR2715459B3 (fr) Brûleur atmosphérique.
IT244702Y1 (it) Aspiratore fumi collodio-acetone per uso clinico